THE US Food and Drug
Administration has approved a
new formulation for Cumberland
Pharmaceuticals’ Acetadote
Injection (acetylcysteine) for the
treatment of acetaminophen
poisoning.
The new formula, which will
replace the currently marketed
product, does not contain ethylene
diamine tetracetic acid or any
stabilisation and chelating agents,
and is also free of preservatives.
MEANWHILE the FDA has also
approved GE Healthcare’s DaTscan
(Ioflupane I 123 Injection), for the
detection of dopamine transporters
in the brains of adult patients with
suspected Parkinsonian syndromes.
See www.fda.gov.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jan 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.